- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04482972
Drug Coated Balloon Only vs Drug Eluting Stent Angioplasty
Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Simon C Eccleshall, MRCP, MD
- Phone Number: 00441603286286
- Email: Simon.eccleshall@nnuh.nhs.uk
Study Contact Backup
- Name: Vassilios S Vassilious, PhD, FRCP
- Email: v.vassiliou@uea.ac.uk
Study Locations
-
-
Norfolk
-
Norwich, Norfolk, United Kingdom, NR4 7UY
- Recruiting
- Norfolk and Norwich University Hospitals NHS Foundation Trust
-
Contact:
- Simon C Eccleshall, MRCP, MD
- Phone Number: 00441603286286
- Email: Simon.eccleshall@nnuh.nhs.uk
-
Contact:
- Vassilious S Vassiliou, PhD, FRCP
- Email: v.vassiliou@uea.ac.uk
-
Sub-Investigator:
- Ioannis Merinopoulos, MRCP
-
Sub-Investigator:
- Tharusha Gunawardena, MRCP
-
Sub-Investigator:
- Upul Wickramarachchi, MRCP
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
DCB
DCB group: Patients treated with drug coated balloon (DCB) only angioplasty (all-comers: STEMI, NSTEMI, Stable angina)
|
Angioplasty with DCB is an angioplasty technique which allows drug delivery to the coronary artery without stent implantation.
|
DES
DES group: Patients treated with drug eluting stent (DES) angioplasty (all-comers:STEMI, NSTEMI, Stable angina)
|
Angioplasty with DES is an angioplasty technique which permits drug delivery to the coronary artery and permanent implantation of a stent.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All-cause mortality
Time Frame: Through study completion, an average of 10 years
|
All cause death will be defined as death due to any cause
|
Through study completion, an average of 10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac mortality - either MI, TVR, Acute Vessel Closure or TLR
Time Frame: Through study completion, an average of 10 years
|
An MI is defined as per MINAP definition (a hospital diagnosis reported as a troponin positive MI). A TVR is defined as any repeat percutaneous intervention or surgical bypass of any segment of the target vessel. The latter is defined as the entire major coronary vessel proximal and distal to the target lesion, including upstream and downstream branches and the target lesion itself. Acute vessel closure is defined as an event where a patient had to be taken back to cardiac catheterisation lab and require repeat angioplasty (during the same hospital stay) for a complete or partial occlusion of the artery due to a dissection. A TLR is defined as any repeat percutaneous intervention of the target lesion or bypass surgery of the target vessel performed for restenosis or other complication of the target lesion. The target lesion is defined as the treated segment from 5 mm proximal and 5 mm distal to the treated lesion (by visual assessment). |
Through study completion, an average of 10 years
|
Cardiac rehospitalisation
Time Frame: Through study completion, an average of 10 years
|
Any hospital record of admission due to cardiac complications
|
Through study completion, an average of 10 years
|
Composite of cardiac death and cardiac rehospitalisation
Time Frame: Through study completion, an average of 10 years
|
Any hospital record of admission and death due to cardiac complications
|
Through study completion, an average of 10 years
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Simon C Eccleshall, Norfolk and Norwich University Hospitals NHS Foundation Trust
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 195002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on DCB
-
Yonsei UniversityRecruitingFemoropopliteal Artery DiseaseKorea, Republic of
-
Xiamen Cardiovascular Hospital, Xiamen UniversityRecruiting
-
Acotec Scientific Co., LtdShanghai Tongji Hospital, Tongji University School of MedicineRecruiting
-
C. R. BardCompletedFemoral Artery Occlusion | Femoral Artery Stenosis | Stenosis of Popliteal Arteries | Occlusion of Popliteal ArteriesChina
-
ReFlow Medical, Inc.Massachusetts General Hospital; Syntropic CorelabCompletedCritical Limb IschemiaDominican Republic
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioEnrolling by invitation
-
VitNovo, Inc.Completed
-
National Taiwan University HospitalTaipei Veterans General Hospital, Taiwan; Development Center for Biotechnology... and other collaboratorsUnknownDementia, Alzheimer TypeTaiwan
-
A2 Healthcare Taiwan CorporationGoldenMed BioTechnologyWithdrawnHepatocellular Carcinoma | Liver Fibrosis | HEPATITIS B CHRONICTaiwan
-
Acotec Scientific Co., LtdRecruitingStenosis of Native Hemodialysis Arteriovenous FistulasChina